Evidence map›Paper›PMID 41631669›Full record

ArticleEmerging microbes & infections2026

Rapid drug resistance prediction in positive

Ebba Rosendal, Joana Isidro, Sofia Carneiro, João Paulo Gomes, Rita Macedo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Emerging microbes & infections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Current Perspectives onInternational journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ebba RosendalECDC Fellowship Programme, Public Health Microbiology path (EUPHEM), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.ORCID 0000-0001-8512-0535
Joana IsidroGenomics and Bioinformatics Unit, Infectious Diseases Department, National Institute of Health Doctor Ricardo Jorge, Lisbon, Portugal.
Sofia CarneiroNational Reference Laboratory for Mycobacteria, Infectious Diseases Department, National Institute of Health Doctor Ricardo Jorge, Lisbon, Portugal.ORCID 0000-0001-7486-2277
João Paulo GomesGenomics and Bioinformatics Unit, Infectious Diseases Department, National Institute of Health Doctor Ricardo Jorge, Lisbon, Portugal.
Rita MacedoNational Reference Laboratory for Mycobacteria, Infectious Diseases Department, National Institute of Health Doctor Ricardo Jorge, Lisbon, Portugal.ORCID 0000-0003-2184-5136

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB) remains a global health challenge, exacerbated by the emergence of drug-resistant

Indexed as

Antitubercular AgentsDrug Resistance, BacterialDrug Resistance, Multiple, BacterialHigh-Throughput Nucleotide SequencingMycobacterium tuberculosisTuberculosis, Multidrug-ResistantTuberculosis, PulmonaryDNA, BacterialGenome, BacterialGenotypeHumansMicrobial Sensitivity TestsWhole Genome SequencingAntitubercular AgentsDNA, Bacterialantimicrobial resistancedrug susceptibility testingMycobacterium tuberculosisNanopore sequencingtargeted sequencingTB

Identifiers

PMID41631669
PMCPMC12903939

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.